FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078504876> ?p ?o ?g. }

• W2078504876 endingPage "699" @default.
• W2078504876 startingPage "691" @default.
• W2078504876 abstract "The clinical impact of polycythemia vera (PV) diagnostic and therapeutic guidelines is still undetermined. In particular, the recommended target of hematocrit (Hct) <0.45 has been recently questioned and alkylating drugs are still used for elderly patients. We revised, according to WHO criteria, 300 PV diagnosis and evaluated the impact on clinical outcome of median Hct and of the strategy to administer anti-thrombotic prophylaxis and to avoid alkylating chemotherapy in almost all patients. Of 226 patients with WHO-confirmed diagnosis (median age 66), 91.3% survived at the median follow-up of 5.84 years and 77.5% are projected alive at 13 years. Eighteen percent had major thrombosis and 2.7% acute myeloid leukemia. Twenty-two percent of patients maintained an Hct <0.45: their overall and thrombosis-free survival are similar to those of patients with a 0.45–0.48 value. Conversely, an Hct >0.48 and a “high thrombotic risk” according to ECLAP criteria were both significantly associated to shorter survival and higher thrombosis risk. Chemotherapy reduced thrombotic events without affecting survival. Our study revealed suboptimal compliance to published guidelines. However, in our casistic characterized by wide use of anti-platelet- and avoidance of alkylating drugs, patients’ survival, although analyzed retrospectively, seemed to have improved compared to old literature data. The optimal Hct target was not clearly defined, although a value <0.48 looks highly advisable." @default.
• W2078504876 created "2016-06-24" @default.
• W2078504876 creator A5013522339 @default.
• W2078504876 creator A5016910093 @default.
• W2078504876 creator A5018139001 @default.
• W2078504876 creator A5018509851 @default.
• W2078504876 creator A5030000816 @default.
• W2078504876 creator A5031590759 @default.
• W2078504876 creator A5055853592 @default.
• W2078504876 creator A5057804347 @default.
• W2078504876 creator A5075432456 @default.
• W2078504876 creator A5076786133 @default.
• W2078504876 creator A5080599868 @default.
• W2078504876 creator A5087781254 @default.
• W2078504876 date "2010-02-10" @default.
• W2078504876 modified "2023-09-25" @default.
• W2078504876 title "A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs" @default.
• W2078504876 cites W1446966563 @default.
• W2078504876 cites W1510874774 @default.
• W2078504876 cites W1963876174 @default.
• W2078504876 cites W1968520935 @default.
• W2078504876 cites W1980568348 @default.
• W2078504876 cites W1985953548 @default.
• W2078504876 cites W1991777175 @default.
• W2078504876 cites W1996591949 @default.
• W2078504876 cites W2010740179 @default.
• W2078504876 cites W2025614458 @default.
• W2078504876 cites W2030018706 @default.
• W2078504876 cites W2042632788 @default.
• W2078504876 cites W2048247098 @default.
• W2078504876 cites W2057360098 @default.
• W2078504876 cites W2086511628 @default.
• W2078504876 cites W2088272024 @default.
• W2078504876 cites W2100791643 @default.
• W2078504876 cites W2112316414 @default.
• W2078504876 cites W2123587611 @default.
• W2078504876 cites W2130983069 @default.
• W2078504876 cites W2144664431 @default.
• W2078504876 cites W2149373649 @default.
• W2078504876 cites W2151757571 @default.
• W2078504876 cites W2159962994 @default.
• W2078504876 cites W2171735954 @default.
• W2078504876 cites W2317624320 @default.
• W2078504876 cites W2399669199 @default.
• W2078504876 cites W4214947912 @default.
• W2078504876 doi "https://doi.org/10.1007/s00277-009-0899-z" @default.
• W2078504876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20146064" @default.
• W2078504876 hasPublicationYear "2010" @default.
• W2078504876 type Work @default.
• W2078504876 sameAs 2078504876 @default.
• W2078504876 citedByCount "53" @default.
• W2078504876 countsByYear W20785048762012 @default.
• W2078504876 countsByYear W20785048762013 @default.
• W2078504876 countsByYear W20785048762014 @default.
• W2078504876 countsByYear W20785048762015 @default.
• W2078504876 countsByYear W20785048762016 @default.
• W2078504876 countsByYear W20785048762017 @default.
• W2078504876 countsByYear W20785048762018 @default.
• W2078504876 countsByYear W20785048762019 @default.
• W2078504876 countsByYear W20785048762020 @default.
• W2078504876 countsByYear W20785048762021 @default.
• W2078504876 countsByYear W20785048762022 @default.
• W2078504876 crossrefType "journal-article" @default.
• W2078504876 hasAuthorship W2078504876A5013522339 @default.
• W2078504876 hasAuthorship W2078504876A5016910093 @default.
• W2078504876 hasAuthorship W2078504876A5018139001 @default.
• W2078504876 hasAuthorship W2078504876A5018509851 @default.
• W2078504876 hasAuthorship W2078504876A5030000816 @default.
• W2078504876 hasAuthorship W2078504876A5031590759 @default.
• W2078504876 hasAuthorship W2078504876A5055853592 @default.
• W2078504876 hasAuthorship W2078504876A5057804347 @default.
• W2078504876 hasAuthorship W2078504876A5075432456 @default.
• W2078504876 hasAuthorship W2078504876A5076786133 @default.
• W2078504876 hasAuthorship W2078504876A5080599868 @default.
• W2078504876 hasAuthorship W2078504876A5087781254 @default.
• W2078504876 hasBestOaLocation W20785048762 @default.
• W2078504876 hasConcept C126322002 @default.
• W2078504876 hasConcept C141071460 @default.
• W2078504876 hasConcept C167135981 @default.
• W2078504876 hasConcept C194409129 @default.
• W2078504876 hasConcept C2776694085 @default.
• W2078504876 hasConcept C2778837598 @default.
• W2078504876 hasConcept C2780868729 @default.
• W2078504876 hasConcept C2780959883 @default.
• W2078504876 hasConcept C71924100 @default.
• W2078504876 hasConcept C90924648 @default.
• W2078504876 hasConceptScore W2078504876C126322002 @default.
• W2078504876 hasConceptScore W2078504876C141071460 @default.
• W2078504876 hasConceptScore W2078504876C167135981 @default.
• W2078504876 hasConceptScore W2078504876C194409129 @default.
• W2078504876 hasConceptScore W2078504876C2776694085 @default.
• W2078504876 hasConceptScore W2078504876C2778837598 @default.
• W2078504876 hasConceptScore W2078504876C2780868729 @default.
• W2078504876 hasConceptScore W2078504876C2780959883 @default.
• W2078504876 hasConceptScore W2078504876C71924100 @default.
• W2078504876 hasConceptScore W2078504876C90924648 @default.
• W2078504876 hasIssue "7" @default.
• W2078504876 hasLocation W20785048761 @default.

• next